Smart Technology Facilitated Patient-centered Venous Thromboembolism Management

Launched by NAVY GENERAL HOSPITAL, BEIJING · Apr 1, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how smart technologies, like mobile apps and wearable devices, can help manage a condition called venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). The goal is to see how a specific mobile application can improve patients’ understanding and management of their condition, ultimately leading to better healthcare practices. Researchers believe that these technologies can make it easier for patients to receive support, education, and timely medical care, especially in areas where healthcare access is limited.

To participate in the trial, individuals need to be at least 18 years old and have either a current or past diagnosis of DVT or PE, or be at high risk for developing these conditions. Participants will need to consent to join the study and should be able to use smartphones or tablets. Those who are pregnant, breastfeeding, or have certain serious health issues that affect their ability to live independently are not eligible. This trial has not yet started recruiting participants, but it aims to gather important information that could improve how VTE is managed in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inpatients ≥18 years of age at admission;
• • Previous or current definitive diagnosis of DVT and/or PE by imaging, or at high risk of VTE at discharge: Padua score ≥4 for medical patients and Caprini score ≥5 for surgical patients.
• • Signed informed consent
• Exclusion Criteria:
• • Mental disorder or combination of other serious diseases leading to incapacity for independent living;
• • Inability to use smartphones, computer tablets and other smart devices;
• • Being pregnant or breastfeeding;
• • Have participated in similar trials or are undergoing other clinical trials.